Welcome to the Alzheimer's Research Center
at the University of Washington (ADRC)
Welcome To The University of Washington Alzheimer's Disease Research Center
We know that there are many more questions than answers when it comes to Alzheimer’s disease. Yet through the hard work and ingenuity of our research team and the generosity of our donors and volunteer participants, we are working to find answers. The questions of Alzheimer’s disease are daunting, but by studying the biological processes that underlie this disease, investigators at the UW ADRC are poised to discover the causes, effective treatments, and prevention strategies for Alzheimer’s disease.
On this website, you will find information about our current clinical trials, overviews about research participation and procedures, explanations about research at our center, a peek into the way that precision medicine can change the landscape of Alzheimer’s disease. We hope that the resources you need are here, but if you would like further information, please call our center.
We also welcome you to explore the website of the UW Memory and Brain Wellness Center (MBWC), which represents the research activities in Alzheimer, Parkinson, and frontotemporal spectrum diseases at the UW and clinical care and community outreach at the MBWC Clinic. The site—featuring in-depth news stories, resources, and community event listings—offers valuable information for people living with memory loss and dementia, the wider community, and researchers and clinicians.
A4, a clincial trial assessing the efficacy of a possible medication to prevent Alzheimer's before it starts.
BIOGEN EMERGE, a global clinical trial assessing the efficacy and safety of monthy doses of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease or prevent dementia.
DOD ADNI, a study of traumatic brain injury, posttraumatic stress disorder, and Alzheimer’s disease for Vietnam-era Veterans
SNIFF, a Phase II/III clinical trial will examine whether intranasal insulin improves memory loss
CONNECT, a drug trial to test whether AZD0530 (saracatinib) slows the progression in mild-stage Alzheimer's disease.
Neuroimaging and Function Study, a study to examine the relationship between brain regions, physical performance and cognitive function in older adults with memory problems.
Pilot Research Awards
Each year, we fund innovative Alzheimer’s-related projects by senior fellows and junior faculty. We award pilot funding to projects that relate to our center’s emphasis on precision medicine and Alzheimer’s. Our long-term vision is to develop the knowledge and technology necessary for optimal targeting and timing of disease-modifying interventions that stop or slow Alzheimer’s disease. For current opportunities, contact Molly Chin (email@example.com).